Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bitopertin in Adults With Non-Transfusion-Dependent Beta-Thalassemia
NCT03271541Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of bitopertin in beta thalassemia, sponsored by Roche. Primary endpoints: Percentage of Participants with Adverse Events, Change in Total Hemoglobin Level and 1 more. Started Oct 2017; status: completed.
02
Drugs
bitopertin
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT03271541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03271541.